scPharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of scPharmaceuticals generated cash of -$59,244,000, which is less than the previous year. Cash used in financing activities reached the amount of $14,850,000 last year. Net change in cash is therefore -$24,429,000.
Cash Flow
| 2015 | -9.64M | -17K | 8.01M |
|---|---|---|---|
| 2016 | -15.45M | -9K | 53.17M |
| 2017 | -22.68M | -194K | 102.07M |
| 2018 | -28.81M | 0 | -8K |
| 2019 | -30.44M | 0 | 13.58M |
| 2020 | -27.69M | -33.46M | 60.34M |
| 2021 | -27.15M | 32.13M | -2.53M |
| 2022 | -34.57M | -45.85M | 77.22M |
| 2023 | -59.24M | 19.96M | 14.85M |
SCPH Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 71.24M | 74.45M | 72.00M | 72.80M | 89.66M | 118.48M | 39.28M | 1.57M | 3.21M |
Operating activities | |||||||||
Net income | -54.81M | -36.83M | -28.03M | -32.20M | -32.99M | -29.44M | -23.81M | -24.37M | -10.51M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 626K | 468K | 438K | 399K | 364K | 332K | 167K | 5K | 4K |
Stock-based compensation expense | 4.85M | 2.83M | 2.36M | 2M | 1.44M | 2.13M | 947K | 876K | 379K |
| Deferred income tax benefit | 4.85M | 2.83M | 2.36M | 2M | 1.44M | 2.13M | 947K | 876K | 379K |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | -4.48M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | -7.60M | -1.23M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 5.55M | 1.76M | -2.36M | 1.21M | 965K | -1.37M | 951K | 1.74M | 974K |
Cash generated by operating activities | -59.24M | -34.57M | -27.15M | -27.69M | -30.44M | -28.81M | -22.68M | -15.45M | -9.64M |
Investing activities | |||||||||
Purchases Of Investments | -50.59M | -67.53M | -9.01M | -72.16M | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -40K | -21K | -9K | 0 | 0 | 0 | -194K | -9K | -17K |
Acquisitions Net | 0 | 45.83M | -32.13M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 19.96M | -45.85M | 32.13M | -33.46M | 0 | 0 | -194K | -9K | -17K |
Financing activities | |||||||||
Common Stock Issued | 14.03M | 47.76M | 51K | 60.57M | 3.97M | 54K | 92.71M | 40.63M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -81K | -164K | 0 | -4K | -3K | 0 | -9K |
Repayments of term debt | 0 | 29.80M | -2.5M | 0 | 9.55M | -62K | 9.27M | -12.53M | 0 |
Cash used in financing activities | 14.85M | 77.22M | -2.53M | 60.34M | 13.58M | -8K | 102.07M | 53.17M | 8.01M |
Net Change In Cash | -24.42M | -3.20M | 2.44M | -805K | -16.85M | -28.82M | 79.19M | 37.70M | -1.64M |
Cash at end of period | 46.81M | 71.24M | 74.45M | 72.00M | 72.80M | 89.66M | 118.48M | 39.28M | 1.57M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |